Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918

This article has now been updated. Please use the final version.

Retroperitoneal Hemorrhage in Patients With COVID-19 Undergoing Hemodialysis: Three Case Reports
Hideaki OkaYoshito HommaYuki NishinoKoichiro SuemoriNorio SatoYuko SakuraiMizuki SekimotoShota AndoSaki IwamotoTakaki IwamotoMika KondoTaro KamimuraToshiaki NakanoTakanari Kitazono
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: 8976-21

Details
Abstract

A 73-year-old man receiving hemodialysis and antiplatelets was admitted with a mild case of COVID-19. Heparin was added, and iliopsoas hemorrhage developed. He was successfully treated by interventional radiology. A 76-year-old man receiving hemodialysis and antiplatelets was admitted with mild COVID-19. Heparin was added, and iliacus hemorrhage developed. Despite heparin discontinuation, he died of worsening pneumonia. A 74-year-old man undergoing hemodialysis was admitted with severe COVID-19. Gastrointestinal bleeding developed during continuous hemodiafiltration with heparin. Upon switching to nafamostat and increasing the dose, iliopsoas hemorrhage developed. Despite interventional radiology, he died of infectious complications. Attention to hemorrhagic complications is therefore needed in patients with COVID-19.

Content from these authors
© 2022 by The Japanese Society of Internal Medicine
feedback
Top